1. Home
  2. BLLN vs PJT Comparison

BLLN vs PJT Comparison

Compare BLLN & PJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

N/A

Current Price

$93.00

Market Cap

4.4B

Sector

Health Care

ML Signal

N/A

Logo PJT Partners Inc.

PJT

PJT Partners Inc.

N/A

Current Price

$181.92

Market Cap

4.4B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BLLN
PJT
Founded
2016
2014
Country
United States
United States
Employees
713
N/A
Industry
Medical Specialities
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.4B
IPO Year
2025
2015

Fundamental Metrics

Financial Performance
Metric
BLLN
PJT
Price
$93.00
$181.92
Analyst Decision
Buy
Buy
Analyst Count
7
4
Target Price
$126.71
$178.50
AVG Volume (30 Days)
797.8K
358.2K
Earning Date
05-06-2026
04-28-2026
Dividend Yield
N/A
0.66%
EPS Growth
103.40
N/A
EPS
0.48
N/A
Revenue
$305,112,000.00
$1,713,671,000.00
Revenue This Year
$46.29
$11.12
Revenue Next Year
$30.14
$9.98
P/E Ratio
$198.23
$23.03
Revenue Growth
99.97
14.77
52 Week Low
$61.96
$127.73
52 Week High
$150.44
$195.62

Technical Indicators

Market Signals
Indicator
BLLN
PJT
Relative Strength Index (RSI) 39.93 61.05
Support Level $88.38 $166.43
Resistance Level $95.82 $195.62
Average True Range (ATR) 4.51 5.25
MACD 0.13 0.26
Stochastic Oscillator 47.48 93.43

Price Performance

Historical Comparison
BLLN
PJT

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About PJT PJT Partners Inc.

PJT Partners Inc is an advisory-focused investment bank that offers a portfolio of advisory services designed to help its clients achieve their strategic objectives. The company delivers a range of strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments around the world. It also provides private fund advisory and fundraising services for alternative investment strategies, including private equity, real estate, hedge funds, and private credit. The company generates its revenue from advisory fees, placement services, and others. Geographically, it generates maximum revenue from the United States, followed by the United Kingdom and other markets.

Share on Social Networks: